LEIDY FOURNIER: Open Payments
NPI 1437693660 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,560 in 80 payments from 18 companies in 2025. Trend: 2023 $987 · 2024 $1,493 · 2025 $1,560
Food & beverage: $1,560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $336 |
| Novo Nordisk Inc | 10 | $302 |
| Lilly USA, LLC | 7 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $116 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Exact Sciences Corporation | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
Products named: Wegovy, VRAYLAR, UBRELVY, AIRSUPRA, REXULTI, MOUNJARO, INGREZZA, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
